<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="mortality rate (Chen etÂ al., 2020). ARDS during a SARS-CoV-2" exact="infection" post="is also associated with dysregulation of cytokine production, barrier"/>
 <result pre="(mouse system) reported that intragastric inoculation of SARS-CoV-2 causes productive" exact="infection" post="and leads to pulmonary pathological changes (Sun etÂ al.,"/>
 <result pre="is not the only site targeted by SARS-CoV-2, and enteric" exact="infection" post="occurs. Here, we review gastrointestinal disorders in patients with"/>
 <result pre="Jin and colleagues enrolled 651 patients on admission, i.e., before" exact="treatment" post="with antiviral or antibiotic drugs, which might have biased"/>
 <result pre="totaling 4,243, 6,686, and 10,890 patients found that the pooled" exact="prevalence" post="of gastrointestinal symptoms was 17.6%, 15%, and 10%, respectively"/>
 <result pre="2020; Mao etÂ al., 2020; Sultan etÂ al., 2020). SARS-CoV-2" exact="infection" post="triggers an inflammatory response in the gut, as evidenced"/>
 <result pre="will be instrumental in better analyzing the modalities of enterocyte" exact="infection" post="and its impact on the inflammatory response. Furthermore, it"/>
 <result pre="expression and impaired function of this protein during a SARS-CoV" exact="infection" post="might substantially contribute to local disorders and pathogenesis. It"/>
 <result pre="system could be affected by SARS-CoV-2, either by direct viral" exact="infection" post="or through the elicited immune response (e.g., inflammatory cytokines),"/>
 <result pre="can speculate that the decrease in ACE2 availability during SARS-COV-2" exact="infection" post="is enough to alter the composition of the gut"/>
 <result pre="microbiota. Recent pilot studies suggest gut microbiota alterations during SARS-CoV-2" exact="infection" post="(Yu etÂ al., 2020; Gu etÂ al., 2020b; Zuo"/>
 <result pre="COVID-19 patients (fecal sample analysis using 16S rRNA gene sequencing)," exact="infection" post="was associated with a significant decrease of bacterial diversity"/>
 <result pre="resiliency is long lasting (Zuo etÂ al., 2020). Hence, SARS-CoV-2" exact="infection" post="modifies the composition of the gut microbiota in humans."/>
 <result pre="discovery to delineate the role of microbiome changes in SARS-CoV-2" exact="infection" post="and post-infection recovery. It will be critical to consider"/>
 <result pre="the comorbidity status of those patients. The consequences of SARS-CoV-2" exact="infection" post="on the gut microbiota should also be investigated in"/>
 <result pre="to gut dysbiosis and gastrointestinal symptoms (step 3). Meanwhile, viral" exact="infection" post="of the lungs triggers the systemic production of interferons"/>
 <result pre="setting of influenza infections, the results of experiments with antibiotic" exact="treatment" post="(to deplete the residual microbiota) have demonstrated that the"/>
 <result pre="in both humans and animal models. Severe influenza A virus" exact="infection" post="is associated with intestinal disorders and gut microbiota alterations"/>
 <result pre="COVID-19 is still an open question. Evidence suggests that SARS-CoV-2" exact="infection" post="alters the gut-blood barrier and thus leads to systemic"/>
 <result pre="2020). This might affect the hostâ€™s initial response to SARS-CoV-2" exact="infection" post="and might then contribute to multisystem dysfunction, septic shock,"/>
 <result pre="in microbial profiles, and intestinal inflammation and leakiness during SARS-CoV" exact="infection" post="strongly amplify systemic pathways in comorbid individuals and exacerbate"/>
 <result pre="individuals and exacerbate underlying pathologies (e.g., diabetes and hypertension). SARS-CoV-2" exact="infection" post="may also deteriorate the course of human inflammatory bowel"/>
 <result pre="(Effenberger etÂ al., 2020). The mortality rate associated with SARS-CoV-2" exact="infection" post="is higher in older adults, who also tend to"/>
 <result pre="a therapeutic option. Concluding Remarks The complex pathogenesis of SARS-CoV-2" exact="infection" post="is only starting to be deciphered. Along with the"/>
 <result pre="explored. In particular, several lines of evidence suggest that SARS-CoV-2" exact="infection" post="is associated with alteration of the gut microbiota. It"/>
 <result pre="attractive therapeutic strategy. In this setting, conventional approaches like antibiotic" exact="treatment" post="targeting pathobionts (preferably with a narrow-spectrum drug), probiotics, and"/>
 <result pre="AntunesK.H.FachiJ.L.de PaulaR.da SilvaE.F.PralL.P.Dos SantosA.Ã�.DiasG.B.M.VargasJ.E.PugaR.MayerF.Q.Microbiota-derived acetate protects against respiratory syncytial virus" exact="infection" post="through a GPR43-type 1 interferon responseNat. Commun.1020193273328931332169 BadawiA.VelummailumR.RyooS.G.SenthinathanA.YaghoubiS.VasilevaD.OstermeierE.PlishkaM.SoosaipillaiM.AroraP.Prevalence of"/>
 <result pre="moderate coronavirus disease 2019J.Â Clin. Invest.13020202620262932217835 CheungK.S.HungI.F.N.ChanP.P.Y.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.H.TamA.R.Gastrointestinal manifestations of SARS-CoV-2" exact="infection" post="and virus load in fecal samples from a Hong"/>
 <result pre="heart functionNature417200282282812075344 DeriuE.BoxxG.M.HeX.PanC.BenavidezS.D.CenL.RozengurtN.ShiW.ChengG.Influenza virus affects intestinal microbiota and secondary Salmonella" exact="infection" post="in the gut through type I interferonsPLoS Pathog.122016e100557227149619 EffenbergerM.GrabherrF.MayrL.SchwaerzlerJ.NairzM.SeifertM.HilbeR.SeiwaldS.Scholl-BuergiS.FritscheG.Faecal"/>
 <result pre="respiratory syndrome coronavirus-2 (SARS-CoV-2)J.Â Med. Virol.92202069970232314810 QinN.ZhengB.YaoJ.GuoL.ZuoJ.WuL.ZhouJ.LiuL.GuoJ.NiS.Influence of H7N9 virus" exact="infection" post="and associated treatment on human gut microbiotaSci. Rep.52015147711478426490635 RanjbarR.ShafieeM.HesariA.FernsG.A.GhasemiF.AvanA.The"/>
 <result pre="(SARS-CoV-2)J.Â Med. Virol.92202069970232314810 QinN.ZhengB.YaoJ.GuoL.ZuoJ.WuL.ZhouJ.LiuL.GuoJ.NiS.Influence of H7N9 virus infection and associated" exact="treatment" post="on human gut microbiotaSci. Rep.52015147711478426490635 RanjbarR.ShafieeM.HesariA.FernsG.A.GhasemiF.AvanA.The potential therapeutic use"/>
 <result pre="RanjbarR.ShafieeM.HesariA.FernsG.A.GhasemiF.AvanA.The potential therapeutic use of renin-angiotensin system inhibitors in the" exact="treatment" post="of inflammatory diseasesJ.Â Cell. Physiol.23420192277229530191985 ReddW.D.ZhouJ.C.HathornK.E.McCartyT.R.BazarbashiA.N.ThompsonC.C.ShenL.ChanW.W.Prevalence and characteristics of"/>
 <result pre="ReddW.D.ZhouJ.C.HathornK.E.McCartyT.R.BazarbashiA.N.ThompsonC.C.ShenL.ChanW.W.Prevalence and characteristics of gastrointestinal symptoms in patients with SARS-CoV-2" exact="infection" post="in the United States: A multicenter cohort studyGastroenterology202010.1053/j.gastro.2020.04.045Published online"/>
 <result pre="COVID-19Gastroenterology202010.1053/j.gastro.2020.05.001Published online May 11, 2020 SunS.-H.ChenQ.GuH.-J.YangG.WangY.-X.HuangX.-Y.LiuS.-S.ZhangN.-N.LiX.-F.XiongR.A mouse model of SARS-CoV-2" exact="infection" post="and pathogenesisCell Host Microbe202010.1016/j.chom.2020.05.020Published online May 27, 2020 SungnakW.HuangN.BÃ©cavinC.BergM.QueenR.LitvinukovaM.Talavera-LÃ³pezC.MaatzH.ReichartD.SampaziotisF.collab:"/>
 <result pre="monocyte hematopoiesis and CD8+ TÂ cell metabolismImmunity4820189921005.e829768180 WangJ.LiF.WeiH.LianZ.-X.SunR.TianZ.Respiratory influenza virus" exact="infection" post="induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammationJ.Â"/>
 <result pre="control and preventionJAMA202010.1001/jama.2020.2648Published online February 24, 2020 XiaoF.TangM.ZhengX.LiuY.LiX.ShanH.Evidence for gastrointestinal" exact="infection" post="of SARS-CoV-2Gastroenterology158202018311833.e332142773 XiaoF.SunJ.XuY.LiF.HuandX.LiH.ZhoaJ.HuangJ.ZhaoJ.Infectious SARS-CoV-2 in feces of patient with"/>
 <result pre="COVID-19Emerg. Infect. Dis.26202010.3201/eid2608.200681Published online May 18, 2020 YildizS.Mazel-SanchezB.KandasamyM.ManicassamyB.SchmolkeM.Influenza A virus" exact="infection" post="impacts systemic microbiota dynamics and causes quantitative enteric dysbiosisMicrobiome6201892529321057"/>
 <result pre="of coronavirus disease 2019medRxiv202010.1101/2020.03.03.20030650 ZangR.Gomez CastroM.F.McCuneB.T.ZengQ.RothlaufP.W.SonnekN.M.LiuZ.BruloisK.F.WangX.GreenbergH.B.TMPRSS2 and TMPRSS4 promote SARS-CoV-2" exact="infection" post="of human small intestinal enterocytesSci. Immunol.52020eabc358232404436 ZhangW.DuR.H.LiB.ZhengX.S.YangX.L.HuB.WangY.Y.XiaoG.F.YanB.ShiZ.L.ZhouP.Molecular and serological"/>
</results>
